Decoding methylation patterns in ovarian cancer using publicly available Next-Gen sequencing data

Ovarian cancer (OC), one of the most frequent forms of cancer among women all over the world, inflicts a substantial danger to the health of human beings. An in-depth comprehension of its latent processes at the molecular level is the answer to evolving successful earmarked therapies. For an effective genomic assay, deep transcriptional sequencing has been used via Next-generation sequencing tools which are beneficial in studying OC and its related counterparts. ChIP-Seq data for a malignant and benign specimen of OC underwent comparison, and identification of differential peaks were carried out based on fold change and peaks were then annotated. BioGRID was employed to perform protein-protein interaction (PPI) network analysis, which was then constructed with Cytoscape. Highly connected genes from the constructed network were then screened. Utilizing the additional data sets from other OC cell lines gave two new classes of genes for which there is no documented role in the progression of the disease. PAX2, PAX5, FOXP1 and KLF16 are some of the promising genes whose presence among differential peaks led to the positive conclusion of their role in OC. Recent literature studies of these genes are also in conformity with the findings. Potential OC-related genes identified through our findings increase the interpretation of OC and thus provide direction for conducting research in near future.

[1]  R. Bast,et al.  The CA 125 tumour-associated antigen: a review of the literature. , 1989, Human reproduction.

[2]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[3]  M. Zannini,et al.  The Interaction between the Forkhead Thyroid Transcription Factor TTF-2 and the Constitutive Factor CTF/NF-1 Is Required for Efficient Hormonal Regulation of the Thyroperoxidase Gene Transcription* , 1999, The Journal of Biological Chemistry.

[4]  Chun-Fang Xu,et al.  Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics , 1999, Oncogene.

[5]  J. Herman,et al.  Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. , 2000, Journal of the National Cancer Institute.

[6]  J. Inazawa,et al.  Identification and characterization of human PKNOX2, a novel homeobox-containing gene. , 2001, Biochemical and biophysical research communications.

[7]  C. Plass,et al.  Methylation matters , 2001, Journal of medical genetics.

[8]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[9]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[10]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[11]  Peter A. Jones,et al.  Epigenetic therapy of cancer: past, present and future , 2006, Nature Reviews Drug Discovery.

[12]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[13]  Michael Weber,et al.  Genomic patterns of DNA methylation: targets and function of an epigenetic mark. , 2007, Current opinion in cell biology.

[14]  Philippe Broët,et al.  HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients , 2007, PloS one.

[15]  M. Busslinger,et al.  Pax5: the guardian of B cell identity and function , 2007, Nature Immunology.

[16]  A. Mortazavi,et al.  Genome-Wide Mapping of in Vivo Protein-DNA Interactions , 2007, Science.

[17]  M. Esteller Epigenetics in cancer. , 2008, The New England journal of medicine.

[18]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[19]  Giovanni Scardoni,et al.  Analyzing biological network parameters with CentiScaPe , 2009, Bioinform..

[20]  D. Scholtens,et al.  Differential methylation profile of ovarian cancer in tissues and plasma. , 2009, The Journal of molecular diagnostics : JMD.

[21]  M. Birrer,et al.  Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study. , 2009, Gynecologic oncology.

[22]  Sven Mahner,et al.  Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines. , 2009, Oncology reports.

[23]  T. Ushijima,et al.  Aberrant DNA methylation in contrast with mutations , 2010, Cancer science.

[24]  Chen Chen,et al.  Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF. , 2010, BMB reports.

[25]  Yu Zhang,et al.  A Generalized Linear Model for Peak Calling in ChIP-Seq Data , 2012, J. Comput. Biol..

[26]  C. Rancourt,et al.  Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis , 2012, Molecular Cancer.

[27]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[28]  Hua Zhao,et al.  Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. , 2012, Gynecologic oncology.

[29]  Jie Zhang,et al.  Practical Guidelines for the Comprehensive Analysis of ChIP-seq Data , 2013, PLoS Comput. Biol..

[30]  Samuel C. Mok,et al.  PAX2 Expression in Ovarian Cancer , 2013, International journal of molecular sciences.

[31]  H. Fan,et al.  YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients , 2014, PloS one.

[32]  D. Spandidos,et al.  DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review) , 2014, Molecular medicine reports.

[33]  Kamal Raj Pardasani,et al.  One Dimensional Finite Element Model to Study Calcium Distribution in Oocytes in Presence of VGCC, RyR and Buffers , 2015 .

[34]  Ji-Ying Song,et al.  Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients , 2016, Cell reports.

[35]  Su In Lee,et al.  FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells , 2015, Oncotarget.

[36]  Pritish Kumar Varadwaj,et al.  Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation , 2016, Journal of biomolecular structure & dynamics.

[37]  Kamal Raj Pardasani,et al.  Finite element model to study calcium distribution in oocytes involving voltage gated Ca2+ channel, ryanodine receptor and buffers , 2016 .

[38]  D. Otteson,et al.  Novel Roles and Mechanism for Krüppel-like Factor 16 (KLF16) Regulation of Neurite Outgrowth and Ephrin Receptor A5 (EphA5) Expression in Retinal Ganglion Cells* , 2016, The Journal of Biological Chemistry.

[39]  John Quackenbush,et al.  Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. , 2016, JCI insight.

[40]  Klaus Hansen,et al.  An interactive environment for agile analysis and visualization of ChIP-sequencing data , 2016, Nature Structural &Molecular Biology.

[41]  Rahul Semwal,et al.  Identification of novel dysregulated key genes in Breast cancer through high throughput ChIP-Seq data analysis , 2017, Scientific Reports.

[42]  Pritish Kumar Varadwaj,et al.  Epigenetics and Its Role in Human Cancer , 2017 .

[43]  Samuel C. Mok,et al.  ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells , 2017, Oncotarget.

[44]  Kamal Raj Pardasani,et al.  Three-Dimensional Finite Element Model to Study Effect of RyR Calcium Channel, ER Leak and SERCA Pump on Calcium Distribution in Oocyte Cell , 2018, International Journal of Computational Methods.

[45]  Kamal Raj Pardasani,et al.  Finite Element Model to Study Calcium Distribution in T Lymphocyte Involving Buffers and Ryanodine Receptors , 2018 .